80 related articles for article (PubMed ID: 6094427)
1. Bactericidal activity of continuously changing cefotaxime concentrations in human blood.
Shah PM
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():103-8. PubMed ID: 6094427
[TBL] [Abstract][Full Text] [Related]
2. Effects of subinhibitory concentrations of cefotaxime on adhesion and polymorphonuclear leukocyte function with gram-negative bacteria.
Bassaris HP; Lianou PE; Votta EG; Papavassiliou JT
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():91-6. PubMed ID: 6094466
[TBL] [Abstract][Full Text] [Related]
3. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
McNamee W; Drusano GL; Tatem BA; Standiford HC
J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers.
Standiford HC; Drusano GL; Forrest A; Tatem B; Plaisance K
Antimicrob Agents Chemother; 1987 Aug; 31(8):1177-82. PubMed ID: 3631942
[TBL] [Abstract][Full Text] [Related]
5. [In vitro comparative bactericidal effect of cefotaxime and cefixime in a kinetic model].
Rolin O; Roche G; Bouanchaud DH
Presse Med; 1989 Oct; 18(32):1569-71. PubMed ID: 2530534
[TBL] [Abstract][Full Text] [Related]
6. Correlation of predicted serum bactericidal activities and values measured in volunteers.
Drusano G; Standiford H; Ryan P; McNamee W; Tatem B; Schimpff S
Eur J Clin Microbiol; 1986 Feb; 5(1):88-92. PubMed ID: 3084247
[TBL] [Abstract][Full Text] [Related]
7. Optimal cefotaxime dosing for gram-negative bacteremia: effective trough serum bactericidal titers and drug concentrations 8 and 12 hr after 1- or 2-gm infusions.
Goodpasture HC; Gerlach EH; Jones RN; Peterie JD
Diagn Microbiol Infect Dis; 1988 Feb; 9(2):97-103. PubMed ID: 3383550
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics and human defence mechanisms: the effects of ampicillin and cefotaxime on intra- and extracellular killing of Salmonella enteritidis.
Long MH; Shapland CE; Leonard LA; Rowland H
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():81-9. PubMed ID: 6094465
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of Sch 34343 alone and in combination with gentamicin.
Shah PM; Schneider K; Stille W
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():165-71. PubMed ID: 3897171
[TBL] [Abstract][Full Text] [Related]
10. [Bactericidal effect of cefotaxime-sulbactam and imipenem combined with gentamicin and/or ciprofloxacin against CTX-1 producing Klebsiella pneumoniae].
Archambaud M; Labau E; Clave D; Suc C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):534-9. PubMed ID: 2677925
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
Oizumi K; Hayashi I; Aonuma S; Konno K
Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of cefotaxime and normal human serum on bactericidal activity against urinary strains of Escherichia coli with capsular antigen K1.
Franiczek R; Jankowski S
Acta Microbiol Pol; 1993; 42(3-4):243-50. PubMed ID: 7516615
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.
Piédrola G; Galan I; Leyva A; Maroto MC
Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171
[TBL] [Abstract][Full Text] [Related]
14. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro.
Labro MT; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1986 Aug; 18(2):233-7. PubMed ID: 3019985
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetic and bactericidal characteristics of oral cefixime.
Brittain DC; Scully BE; Hirose T; Neu HC
Clin Pharmacol Ther; 1985 Nov; 38(5):590-4. PubMed ID: 4053491
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663
[TBL] [Abstract][Full Text] [Related]
17. Activity of third-generation cephalosporins in human blood.
Shah PM; Jaenisch E
Clin Ther; 1983; 6(1):72-8. PubMed ID: 6325006
[TBL] [Abstract][Full Text] [Related]
18. [Fundamental and clinical investigations of cefotaxime in neonates].
Hashira S; Koike Y; Fujii R
Jpn J Antibiot; 1982 Jul; 35(7):1737-48. PubMed ID: 6294355
[TBL] [Abstract][Full Text] [Related]
19. [Comparative antibacterial activity of ceftibuten (SH 39 720) against 150 K. pneumoniae strains producing different beta-lactamases].
Thabaut A; Meyran M
Pathol Biol (Paris); 1990 May; 38(5):347-51. PubMed ID: 2195446
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory and bactericidal activity of cefpirome and cefotaxime against blood culture isolates.
Ansorg R; Primavesi CA; von Recklinghausen G
Chemotherapy; 1990; 36(1):24-8. PubMed ID: 2106417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
